Cartilaginous - ClinicalTrials.gov

A Randomized, Controlled, Comparative, Single-blinded, Multi-center Study Evaluating JointRep® and Microfracture in Repair of Focal Articular Cartilage Lesions on the Femoral Condyle or Trochlea, The JMAC Trial.

JMAC's research, which is an international multicenter Randomized Controlled Trial, is designed to determine the efficiency and safety of JointRepu00ae, a second-generation chitosan-based hydrogel for cartilage repair, and its durability. A total of 185 people will be randomly assigned either Microfracture Plus JointRepu00ae or Microfracture alone. Quality of the new tissue is also based and blindly measured, determining the T2 level, while the upper and lower half of the new tissue T2 test will determine the degree of stratification of the new cartilaginous tissue.

Source link: https://clinicaltrials.gov/ct2/show/NCT04840147

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions